Risk Assessment and Outcome Prediction in Pulmonary Embolism
https://doi.org/10.35401/2541-9897-2025-10-4-129-135
Abstract
Pulmonary embolism remains one of the leading causes of mortality worldwide. Timely diagnosis and treatment can improve both survival rates and the long-term quality of life in patients. The pre-test probability stratification for pulmonary embolism enables the exclusion of diagnostic methods associated with potential complications due to both radiation exposure and contrast agent administration.
The article presents scales for assessing the probability of pulmonary embolism, the risk of complications, adverse outcomes, and recurrence of thromboembolism. The advantages and disadvantages of the presented scales for practical use are discussed, along with specific considerations for their use in different patient groups.
About the Authors
T. I. Akimenko
Saint Petersburg State Pediatric Medical University; Pokrovskaya City Hospital
Россия
Россия
Tatiana I. Akimenko, Cand. Sci. (Med.), Associate Professor, Department of Anesthesiology, Resuscitation and Emergency Pediatrics, Faculty of Postgraduate and Continuing Professional Education, Saint Petersburg State Pediatric Medical University; Anesthesiologist-Intensivist, Cardiac Intensive Care Unit, Pokrovskaya City Hospital
ulitsa Litovskaya 2, Saint Petersburg, 194100
Yu. S. Aleksandrovich
Saint Petersburg State Pediatric Medical University
Россия
Россия
Yurii S. Aleksandrovich, Dr. Sci. (Med.), Professor, Head of the Department of Anesthesiology, Resuscitation and Emergency Pediatrics, Faculty of Postgraduate and Continuing Professional Education
Saint Petersburg
S. A. Razumov
Astana Medical University
Казахстан
Казахстан
Sergey A. Razumov, Cand. Sci. (Med.), Professor, Department of Anesthesiology and Intensive Care Unit No. 1, Astana Medical University; Independent Expert in Pediatric Anesthesiology and Intensive Care of the Ministry of Health of the Republic of Kazakhstan
Astana
References
1. Nikulina NN, Terekhovskaya YuV. Epidemiology of pulmonary embolism in today’s context: analysis of incidence, mortality and problems of their study. Russian Journal of Cardiology. 2019;24(6):103– 108. (In Russ.). https://doi.org/10.15829/1560-4071-2019-6-103-108
2. Taranov EV, Pastukhova NK, Pichugin VV, et al. Comparative assessment of the effect of anesthetics (propofol, sevoflurane, desflurane) on hemodynamics and gas exchange in the lungs during operations for acute pulmonary embolism. Messenger of ANESTHESIOLOGY AND RESUSCITATION. 2024;21(3):64–75. (In Russ.). https://doi.org/10.24884/2078-5658-2024-21-3-64-75
3. Claeys MJ, Vandekerckhove Y, Cosyns B, Van de Borne P, Lancellotti P. Summary of 2019 ESC Guidelines on chronic coronary syndromes, acute pulmonary embolism, supraventricular tachycardia and dislipidaemias. Acta Cardiol. 2021;76(1):1-8. PMID:
4. https://doi.org/10.1080/00015385.2019.1699282
5. Caprini Risk Score. Caprini Risk Score for Blood Clots. https://capriniriskscore.org/. Accessed December 15,2024.
6. Аvdeeva NN, Sumin SА, Tyapina SV, Volkova NА, Zhabin SN. Anticoagulant Therapy of Acute Pulmonary Embolism with Right Heart Thrombi. Messenger of ANESTHESIO¬ LOGY AND RESUSCITATION. 2021;18(3):87–92. (In Russ.). https://doi.org/10.21292/2078-5658-2021-18-3-87-92
7. Aleksandrovich YS, Gordeev VI. Otsenochnye i prognosticheskie shkaly v meditsine kriticheskikh sostoyanii. 4th ed. Saint Petersburg: Medizdat-SPb; 2020. (In Russ.).
8. Yunfeng Z., Yi C., Hongwei W. et al. The Legend score synthesizes Wells, PERC, Geneva, D-dimer and predicts acute pulmonary embolism prior to imaging tests. Pulmonology. 2023;10:S2531- 0437(23)00195-2. http://doi.org/0.1016/j.pulmoe.2023.10.002.
9. Chazova IE, Martynyuk TV, Valieva ZS, Azizov VA, Akchurin RS, Ansheles AA, et al. Eurasian Association of Cardiology (EAC) Guidelines for the Diagnosis and Treatment of Chronic Thromboembolic Pulmonary Hypertension (2020). Eurasian heart journal. 2021;(1):6– 43. (In Russ.). https://doi.org/10.38109/2225-1685-2021-1-6-43
10. Shen JH, Chen HL, Chen JR, Xing JL, Gu P, Zhu BF. Comparison of the Wells score with the revised Geneva score for assessing suspected pulmonary embolism: a systematic review and meta-analysis. J Thromb Thrombolysis. 2016;41(3):482-492. PMID:
11. https://doi.org/10.1007/s11239-015-1250-2
12. Gavrilov D.V., Andrejchenko A.E., Ermak A.D., Kuzneczova T. Yu., Gusev A.V. Assessment of pulmonary embolism probability using a machine learning model. Russian Journal of Cardiology. 2024;29(4):109-119. (In Russ.). https://doi.org/10.15829/1560-4071-2024-5679.
13. van der Hulle T, Cheung WY, Kooij S, et al. Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study. Lancet. 2017;390(10091):289-297. PMID: 28549662. https://doi.org/10.1016/s0140-6736(17)30885-1
14. Kahn SR, de Wit K. Pulmonary Embolism. N Engl J Med. 2022;387(1):45-57. PMID: 35793208. https://doi.org/10.1056/nejmcp2116489
15. Stals MAM, Beenen LFM, Coppens M, et al. Performance of the 4-Level Pulmonary Embolism Clinical Probability Score (4PEPS) in the diagnostic management of pulmonary embolism: An external validation study. Thromb Res. 2023;231:65-75. PMID:
16. https://doi.org/10.1016/j.thromres.2023.09.010
17. Righini M, Van Es J, Den Exter PL, et al. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. JAMA. 2014;311(11):1117-1124. PMID:
18. https://doi.org/10.1001/jama.2014.2135
19. van der Pol LM, Dronkers CEA, van der Hulle T, et al. The YEARS algorithm for suspected pulmonary embolism: shorter visit time and reduced costs at the emergency department. J Thromb Haemost. 2018;16(4):725-733. PMID: 29431911. https://doi.org/10.1111/jth.13972
20. van der Pol LM, Tromeur C, Bistervels IM, et al. Pregnancy-Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary Embolism. N Engl J Med. 2019;380(12):1139-1149. PMID:
21. https://doi.org/10.1056/nejmoa1813865
22. Erlikh A.D., Barbarash O.L., Berns S.A., Shmidt E.A., Duplyakov D.V. SIRENA score for in-hospital mortality risk assessment in patients with acute pulmonary embolism. Russian Journal of Cardiology. 2020;25(4S):4231. (In Russ.). https://doi. org/10.15829/1560-4071-2020-4231
23. Cherepanova NA, Erlikh AD, Pavlova TV, Mullova IS, Duplyakov DV. Validation of the SIRENA score for assessing the risk of inhospital mortality in patients with acute pulmonary embolism in an independent sample. Russian Journal of Cardiology. 2022;27(2S):4984. (In Russ.). https://doi.org/10.15829/1560-4071-2022-4984
24. Yaman M, Orak M, Durgun HM, et al. The prognostic value of HALP score and sPESI in predicting in-hospital mortality in patients with pulmonary thromboembolism. Postgrad Med J. 2024;101(1191):60-65. PMID: 39301789. https://doi.org/10.1093/postmj/qgae124
25. Marginean A, Arora P, Walsh K, et al. Utilization of a Novel Scoring System in Predicting 30-day Mortality in Acute Pulmonary Embolism, the CLOT-5 Pilot Study. Clin Appl Thromb Hemost. 2024;30:10760296241278353. PMID: 39183532. PMCID: PMC11348478. https://doi.org/10.1177/10760296241278353
26. Mullova IS, Cherepanova NA, Pavlova TV, et al. GRACE score in assessing the risk of hospital outcomes in patients with pulmonary embolism. Russian Journal of Cardiology. 2018;23(12):25– 31. (In Russ.). https://doi.org/10.15829/1560-4071-2018-12-25-31
27. Allgöwer M, Burri C. Shock index. Dtsch Med Wochenschr. 1967;92(43):1947-1950.
28. Cherepanova NA. Effektivnost i bezopasnost tromboliticheskoi terapii u patsientov s tromboemboliei legochnoi arterii nevisokogo riska [dissertation abstract]. Samara: Samara State Medical University; 2023.
29. Sam A, Sánchez D, Gómez V, et al. The shock index and the simplified PESI for identification of low-risk patients with acute pulmonary embolism. Eur Respir J. 2011;37(4):762-766. PMID:
30. https://doi.org/10.1183/09031936.00070110
31. Chen X, Shao X, Zhang Y, et al. Assessment of the Bova score for risk stratification of acute normotensive pulmonary embolism: A systematic review and meta-analysis. Thromb Res. 2020;193:99-106. PMID: 32534329. https://doi.org/10.1016/j.thromres.2020.05.047
32. Kochmareva EA, Kokorin VA, Gordeev IG. The new bedside ROCky score to predict the complications in patients with intermediate-risk pulmonary embolism. Eur J Intern Med. 2018;57:58- 60. PMID: 29866478. https://doi.org/10.1016/j.ejim.2018.05.036
33. Chopard R, Piazza G, Falvo N, et al. An Original Risk Score to Predict Early Major Bleeding in Acute Pulmonary Embolism: The Syncope, Anemia, Renal Dysfunction (PE-SARD) Bleeding Score. Chest. 2021;160(5):1832-1843. PMID: 34217683. https://doi.org/10.1016/j.chest.2021.06.048
34. Chopard R, Bertoletti L, Piazza G, et al. External validation of the PE-SARD risk score for predicting early bleeding in acute pulmonary embolism in the RIETE Registry. Thromb Res.
35. ;235:22-31. PMID: 38295598. https://doi.org/10.1016/ j.thromres.2024.01.013
36. Badescu MC, Ciocoiu M, Badulescu OV, et al. Prediction of bleeding events using the VTE-BLEED risk score in patients with venous thromboembolism receiving anticoagulant therapy (Review). Exp Ther Med. 2021;22(5):1344. PMID: 34630698. PMCID: PMC8495538. https://doi.org/10.3892/etm.2021.10779
37. Lecumberri R, Jiménez L, Ruiz-Artacho P, et al. Prediction of Major Bleeding in Anticoagulated Patients for Venous Thromboembolism: Comparison of the RIETE and the VTE-BLEED Scores. TH Open. 2021;5(3):e319-e328. PMID: 34568742. PMCID: PMC8459175. https://doi.org/10.1055/s-0041-1729171
38. Decousus H, Tapson VF, Bergmann JF, et al. Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators. Chest. 2011;139(1):69-79. PMID: 20453069. https://doi.org/10.1378/chest.09-3081
39. Barbar S, Noventa F, Rossetto V, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost. 2010;8(11):2450-2457. PMID: 20738765. https://doi.org/10.1111/j.1538-7836.2010.04044.x
40. Seliverstov EI, Lobastov KV, Ilyukhin EA, et al. Prevention, Diagnostics and Treatment of Deep Vein Thrombosis. Russian Experts Consensus. Journal of Venous Disorders. 2023;17(3):152. (In Russ.). https://doi.org/10.17116/flebo202317031152
41. Kyrle PA, Eischer L, Šinkovec H, et al. The Vienna Prediction Model for identifying patients at low risk of recurrent venous thromboembolism: a prospective cohort study. Eur Heart J. 2024;45(1):45-53. PMID: 37769352. PMCID: PMC10757868. https://doi.org/10.1093/eurheartj/ehad618
Review
For citations:
Akimenko T.I., Aleksandrovich Yu.S., Razumov S.A. Risk Assessment and Outcome Prediction in Pulmonary Embolism. Innovative Medicine of Kuban. 2025;10(4):129-135. (In Russ.) https://doi.org/10.35401/2541-9897-2025-10-4-129-135
Views:
779
JATS XML
Email this article 
